Organisation paid for research Program year 2024 Source: CMS Open Payments

Cedars Sinai Medcl Ctr

Neither a doctor nor a teaching hospital

Research payments

$289,849

105 payments

Through program year 2024, Cedars Sinai Medcl Ctr is reported as receiving $289,849 in research payments, across 105 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$201,366	84
2023	Research	$61,198	16
2022	Research	$2,069	2
2021	Research	$16,116	2
2019	Research	$9,100	1

Breakdown

Who paid Research payments · program years 2019–2024

Janssen Research & Development, LLC $262,564 100 payments
Boehringer Ingelheim International GmbH $18,049 3 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $9,100 1 payment
Boehringer Ingelheim Pharma GmbH & Co.KG $136 1 payment

Studies the money was for Research payments · program years 2019–2024

78934804Uco2001 $233,907 92 payments
78934804Crd2001 $28,657 8 payments
BI 754091 first-in-man dose escalation $15,980 1 payment
COPD pragmatic randomised clinical trial $9,100 1 payment
BI 754091 first in man dose escalation $1,950 1 payment
Safety & Efficacy of Empa in patients with Acute HF $136 1 payment
PDE4 Phase III trial in IPF patients $119 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.